ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposome Drug Delivery Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-21Z496
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liposome Drug Delivery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Liposome Drug Delivery Market Research Report 2026

Code: QYRE-Auto-21Z496
Report
2026-02-11
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma -Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Johnson & Johnson

Liposome Drug Delivery Market Size

The global Liposome Drug Delivery market was valued at US$ 5289 million in 2025 and is anticipated to reach US$ 12150 million by 2032, at a CAGR of 12.8% from 2026 to 2032.

Liposome Drug Delivery Market

Liposome Drug Delivery Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Liposome Drug Delivery competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
This report delivers a comprehensive overview of the global Liposome Drug Delivery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Liposome Drug Delivery. The Liposome Drug Delivery market size, estimates, and forecasts are provided in terms of sales volume (K Vial) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Liposome Drug Delivery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Liposome Drug Delivery Market Report

Report Metric Details
Report Name Liposome Drug Delivery Market
Accounted market size in 2025 US$ 5289 in million
Forecasted market size in 2032 US$ 12150 million
CAGR 12.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
by Application
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Liposome Drug Delivery manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Liposome Drug Delivery sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Liposome Drug Delivery Market growing?

Ans: The Liposome Drug Delivery Market witnessing a CAGR of 12.8% during the forecast period 2026-2032.

What is the Liposome Drug Delivery Market size in 2032?

Ans: The Liposome Drug Delivery Market size in 2032 will be US$ 12150 million.

What is the market share of major companies in Liposome Drug Delivery Market?

Ans: Global top five manufacturers hold a share about 60%.

What is the Liposome Drug Delivery Market share by type?

Ans: In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%.

Who are the main players in the Liposome Drug Delivery Market report?

Ans: The main players in the Liposome Drug Delivery Market are Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang

What are the Application segmentation covered in the Liposome Drug Delivery Market report?

Ans: The Applications covered in the Liposome Drug Delivery Market report are Fungal Infection Therapy, Cancer & Tumor Therapy, Others

What are the Type segmentation covered in the Liposome Drug Delivery Market report?

Ans: The Types covered in the Liposome Drug Delivery Market report are Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

1 Liposome Drug Delivery Market Overview
1.1 Product Definition
1.2 Liposome Drug Delivery by Type
1.2.1 Global Liposome Drug Delivery Market Value by Type: 2025 vs 2032
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery by Application
1.3.1 Global Liposome Drug Delivery Market Value by Application: 2025 vs 2032
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposome Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposome Drug Delivery Revenue 2021–2032
1.4.2 Global Liposome Drug Delivery Sales 2021–2032
1.4.3 Global Liposome Drug Delivery Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Liposome Drug Delivery Market Competition by Manufacturers
2.1 Global Liposome Drug Delivery Sales Market Share by Manufacturers (2021–2026)
2.2 Global Liposome Drug Delivery Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Liposome Drug Delivery Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Liposome Drug Delivery, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Liposome Drug Delivery, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Liposome Drug Delivery, Product Types and Applications
2.7 Global Key Manufacturers of Liposome Drug Delivery, Date of Entry into the Industry
2.8 Global Liposome Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Liposome Drug Delivery Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Liposome Drug Delivery Players Market Share by Revenue
2.8.3 Global Liposome Drug Delivery Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liposome Drug Delivery Market Scenario by Region
3.1 Global Liposome Drug Delivery Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Liposome Drug Delivery Sales by Region: 2021–2032
3.2.1 Global Liposome Drug Delivery Sales by Region: 2021–2026
3.2.2 Global Liposome Drug Delivery Sales by Region: 2027–2032
3.3 Global Liposome Drug Delivery Revenue by Region: 2021–2032
3.3.1 Global Liposome Drug Delivery Revenue by Region: 2021–2026
3.3.2 Global Liposome Drug Delivery Revenue by Region: 2027–2032
3.4 North America Liposome Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposome Drug Delivery Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Liposome Drug Delivery Sales by Country (2021–2032)
3.4.3 North America Liposome Drug Delivery Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liposome Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposome Drug Delivery Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Liposome Drug Delivery Sales by Country (2021–2032)
3.5.3 Europe Liposome Drug Delivery Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Liposome Drug Delivery Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Liposome Drug Delivery Sales by Region (2021–2032)
3.6.3 Asia Pacific Liposome Drug Delivery Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Liposome Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposome Drug Delivery Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Liposome Drug Delivery Sales by Country (2021–2032)
3.7.3 Latin America Liposome Drug Delivery Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposome Drug Delivery Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2021–2032)
3.8.3 Middle East and Africa Liposome Drug Delivery Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Liposome Drug Delivery Sales by Type (2021–2032)
4.1.1 Global Liposome Drug Delivery Sales by Type (2021–2026)
4.1.2 Global Liposome Drug Delivery Sales by Type (2027–2032)
4.1.3 Global Liposome Drug Delivery Sales Market Share by Type (2021–2032)
4.2 Global Liposome Drug Delivery Revenue by Type (2021–2032)
4.2.1 Global Liposome Drug Delivery Revenue by Type (2021–2026)
4.2.2 Global Liposome Drug Delivery Revenue by Type (2027–2032)
4.2.3 Global Liposome Drug Delivery Revenue Market Share by Type (2021–2032)
4.3 Global Liposome Drug Delivery Price by Type (2021–2032)
5 Segment by Application
5.1 Global Liposome Drug Delivery Sales by Application (2021–2032)
5.1.1 Global Liposome Drug Delivery Sales by Application (2021–2026)
5.1.2 Global Liposome Drug Delivery Sales by Application (2027–2032)
5.1.3 Global Liposome Drug Delivery Sales Market Share by Application (2021–2032)
5.2 Global Liposome Drug Delivery Revenue by Application (2021–2032)
5.2.1 Global Liposome Drug Delivery Revenue by Application (2021–2026)
5.2.2 Global Liposome Drug Delivery Revenue by Application (2027–2032)
5.2.3 Global Liposome Drug Delivery Revenue Market Share by Application (2021–2032)
5.3 Global Liposome Drug Delivery Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Pacira
6.2.1 Pacira Company Information
6.2.2 Pacira Description and Business Overview
6.2.3 Pacira Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pacira Liposome Drug Delivery Product Portfolio
6.2.5 Pacira Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Company Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Luye Pharma
6.5.1 Luye Pharma Company Information
6.5.2 Luye Pharma Description and Business Overview
6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments/Updates
6.6 Sigma-Tau
6.6.1 Sigma-Tau Company Information
6.6.2 Sigma-Tau Description and Business Overview
6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Recent Developments/Updates
6.7 Ipsen (Onivyde)
6.7.1 Ipsen (Onivyde) Company Information
6.7.2 Ipsen (Onivyde) Description and Business Overview
6.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
6.7.5 Ipsen (Onivyde) Recent Developments/Updates
6.8 CSPC
6.8.1 CSPC Company Information
6.8.2 CSPC Description and Business Overview
6.8.3 CSPC Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSPC Liposome Drug Delivery Product Portfolio
6.8.5 CSPC Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Company Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis Liposome Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Fudan-Zhangjiang
6.11.1 Fudan-Zhangjiang Company Information
6.11.2 Fudan-Zhangjiang Description and Business Overview
6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
6.11.5 Fudan-Zhangjiang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposome Drug Delivery Industry Chain Analysis
7.2 Liposome Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposome Drug Delivery Production Mode & Process Analysis
7.4 Liposome Drug Delivery Sales and Marketing
7.4.1 Liposome Drug Delivery Sales Channels
7.4.2 Liposome Drug Delivery Distributors
7.5 Liposome Drug Delivery Customer Analysis
8 Liposome Drug Delivery Market Dynamics
8.1 Liposome Drug Delivery Industry Trends
8.2 Liposome Drug Delivery Market Drivers
8.3 Liposome Drug Delivery Market Challenges
8.4 Liposome Drug Delivery Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma -Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Johnson & Johnson
List of Tables
 Table 1. Global Liposome Drug Delivery Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Liposome Drug Delivery Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Liposome Drug Delivery Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Liposome Drug Delivery Sales (K Vial) of Key Manufacturers (2021–2026)
 Table 5. Global Liposome Drug Delivery Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Liposome Drug Delivery Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Liposome Drug Delivery Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Liposome Drug Delivery Average Price (USD/Vial) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Liposome Drug Delivery, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Liposome Drug Delivery, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Liposome Drug Delivery, Product Types and Applications
 Table 12. Global Key Manufacturers of Liposome Drug Delivery, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Liposome Drug Delivery Companies by Tier (Tier 1, Tier 2, Tier 3), based on Liposome Drug Delivery Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Liposome Drug Delivery Sales by Region (K Vial), 2021–2026
 Table 18. Global Liposome Drug Delivery Sales Market Share by Region (2021–2026)
 Table 19. Global Liposome Drug Delivery Sales by Region (K Vial), 2027–2032
 Table 20. Global Liposome Drug Delivery Sales Market Share by Region (2027–2032)
 Table 21. Global Liposome Drug Delivery Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Liposome Drug Delivery Revenue Market Share by Region (2021–2026)
 Table 23. Global Liposome Drug Delivery Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Liposome Drug Delivery Revenue Market Share by Region (2027–2032)
 Table 25. North America Liposome Drug Delivery Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Liposome Drug Delivery Sales by Country (K Vial), 2021–2026
 Table 27. North America Liposome Drug Delivery Sales by Country (K Vial), 2027–2032
 Table 28. North America Liposome Drug Delivery Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Liposome Drug Delivery Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Liposome Drug Delivery Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Liposome Drug Delivery Sales by Country (K Vial), 2021–2026
 Table 32. Europe Liposome Drug Delivery Sales by Country (K Vial), 2027–2032
 Table 33. Europe Liposome Drug Delivery Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Liposome Drug Delivery Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Liposome Drug Delivery Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Liposome Drug Delivery Sales by Region (K Vial), 2021–2026
 Table 37. Asia Pacific Liposome Drug Delivery Sales by Region (K Vial), 2027–2032
 Table 38. Asia Pacific Liposome Drug Delivery Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Liposome Drug Delivery Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Liposome Drug Delivery Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Liposome Drug Delivery Sales by Country (K Vial), 2021–2026
 Table 42. Latin America Liposome Drug Delivery Sales by Country (K Vial), 2027–2032
 Table 43. Latin America Liposome Drug Delivery Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Liposome Drug Delivery Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Liposome Drug Delivery Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Liposome Drug Delivery Sales by Country (K Vial), 2021–2026
 Table 47. Middle East and Africa Liposome Drug Delivery Sales by Country (K Vial), 2027–2032
 Table 48. Middle East and Africa Liposome Drug Delivery Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Liposome Drug Delivery Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Liposome Drug Delivery Sales (K Vial) by Type (2021–2026)
 Table 51. Global Liposome Drug Delivery Sales (K Vial) by Type (2027–2032)
 Table 52. Global Liposome Drug Delivery Sales Market Share by Type (2021–2026)
 Table 53. Global Liposome Drug Delivery Sales Market Share by Type (2027–2032)
 Table 54. Global Liposome Drug Delivery Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Liposome Drug Delivery Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Liposome Drug Delivery Revenue Market Share by Type (2021–2026)
 Table 57. Global Liposome Drug Delivery Revenue Market Share by Type (2027–2032)
 Table 58. Global Liposome Drug Delivery Price (USD/Vial) by Type (2021–2026)
 Table 59. Global Liposome Drug Delivery Price (USD/Vial) by Type (2027–2032)
 Table 60. Global Liposome Drug Delivery Sales (K Vial) by Application (2021–2026)
 Table 61. Global Liposome Drug Delivery Sales (K Vial) by Application (2027–2032)
 Table 62. Global Liposome Drug Delivery Sales Market Share by Application (2021–2026)
 Table 63. Global Liposome Drug Delivery Sales Market Share by Application (2027–2032)
 Table 64. Global Liposome Drug Delivery Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Liposome Drug Delivery Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Liposome Drug Delivery Revenue Market Share by Application (2021–2026)
 Table 67. Global Liposome Drug Delivery Revenue Market Share by Application (2027–2032)
 Table 68. Global Liposome Drug Delivery Price (USD/Vial) by Application (2021–2026)
 Table 69. Global Liposome Drug Delivery Price (USD/Vial) by Application (2027–2032)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 73. Gilead Sciences Liposome Drug Delivery Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. Pacira Company Information
 Table 76. Pacira Description and Business Overview
 Table 77. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 78. Pacira Liposome Drug Delivery Product
 Table 79. Pacira Recent Developments/Updates
 Table 80. Sun Pharmaceutical Company Information
 Table 81. Sun Pharmaceutical Description and Business Overview
 Table 82. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 83. Sun Pharmaceutical Liposome Drug Delivery Product
 Table 84. Sun Pharmaceutical Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 88. Johnson & Johnson Liposome Drug Delivery Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Luye Pharma Company Information
 Table 91. Luye Pharma Description and Business Overview
 Table 92. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 93. Luye Pharma Liposome Drug Delivery Product
 Table 94. Luye Pharma Recent Developments/Updates
 Table 95. Sigma-Tau Company Information
 Table 96. Sigma-Tau Description and Business Overview
 Table 97. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 98. Sigma-Tau Liposome Drug Delivery Product
 Table 99. Sigma-Tau Recent Developments/Updates
 Table 100. Ipsen (Onivyde) Company Information
 Table 101. Ipsen (Onivyde) Description and Business Overview
 Table 102. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 103. Ipsen (Onivyde) Liposome Drug Delivery Product
 Table 104. Ipsen (Onivyde) Recent Developments/Updates
 Table 105. CSPC Company Information
 Table 106. CSPC Description and Business Overview
 Table 107. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 108. CSPC Liposome Drug Delivery Product
 Table 109. CSPC Recent Developments/Updates
 Table 110. Teva Pharmaceutical Company Information
 Table 111. Teva Pharmaceutical Description and Business Overview
 Table 112. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 113. Teva Pharmaceutical Liposome Drug Delivery Product
 Table 114. Teva Pharmaceutical Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 118. Novartis Liposome Drug Delivery Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Fudan-Zhangjiang Company Information
 Table 121. Fudan-Zhangjiang Description and Business Overview
 Table 122. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial), and Gross Margin (2021–2026)
 Table 123. Fudan-Zhangjiang Liposome Drug Delivery Product
 Table 124. Fudan-Zhangjiang Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Liposome Drug Delivery Distributors List
 Table 128. Liposome Drug Delivery Customers List
 Table 129. Liposome Drug Delivery Market Trends
 Table 130. Liposome Drug Delivery Market Drivers
 Table 131. Liposome Drug Delivery Market Challenges
 Table 132. Liposome Drug Delivery Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Liposome Drug Delivery
 Figure 2. Global Liposome Drug Delivery Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Liposome Drug Delivery Market Share by Type: 2025 & 2032
 Figure 4. Liposomal Doxorubicin Product Picture
 Figure 5. Liposomal Amphoteracin B Product Picture
 Figure 6. Liposomal Paclitaxel Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Liposome Drug Delivery Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Liposome Drug Delivery Market Share by Application: 2025 & 2032
 Figure 10. Fungal Infection Therapy
 Figure 11. Cancer & Tumor Therapy
 Figure 12. Others
 Figure 13. Global Liposome Drug Delivery Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Liposome Drug Delivery Market Size (US$ Million), 2021–2032
 Figure 15. Global Liposome Drug Delivery Sales (K Vial), 2021–2032
 Figure 16. Global Liposome Drug Delivery Average Price (USD/Vial), 2021–2032
 Figure 17. Liposome Drug Delivery Report Years Considered
 Figure 18. Liposome Drug Delivery Sales Share by Manufacturers in 2025
 Figure 19. Global Liposome Drug Delivery Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Liposome Drug Delivery Players: Market Share by Revenue in Liposome Drug Delivery in 2025
 Figure 21. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Liposome Drug Delivery Sales Market Share by Country (2021–2032)
 Figure 24. North America Liposome Drug Delivery Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Liposome Drug Delivery Sales Market Share by Country (2021–2032)
 Figure 28. Europe Liposome Drug Delivery Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Liposome Drug Delivery Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Liposome Drug Delivery Revenue Market Share by Region (2021–2032)
 Figure 36. China Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Liposome Drug Delivery Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Liposome Drug Delivery Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. U.A.E Liposome Drug Delivery Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Liposome Drug Delivery by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Liposome Drug Delivery by Type (2021–2032)
 Figure 58. Global Liposome Drug Delivery Price (USD/Vial) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Liposome Drug Delivery by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Liposome Drug Delivery by Application (2021–2032)
 Figure 61. Global Liposome Drug Delivery Price (USD/Vial) by Application (2021–2032)
 Figure 62. Liposome Drug Delivery Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Market Insights Forecast to 2030
Global Liposome Injection Market Research Report 2025
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microsphere Liposomes Market Research Report 2024
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Development Service Market Research Report 2025
Global Liposome Microsphere Market Research Report 2024
Liposome for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome for Cosmetic Ingredients Market Research Report 2025
Global liposomes in Skin Care Market Research Report 2025
Liposomes for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Contract Manufacturing Market Research Report 2024
Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions